Newsroom | 11034 results

Sorted by: Latest

Surgery
-

Hospital Leaders Call for Action to Protect Healthcare in Oklahoma

OKLAHOMA CITY--(BUSINESS WIRE)--As the Senate prepares to vote on a budget reconciliation bill that would have devastating impacts on healthcare access in Oklahoma, hospital administrators will share how Medicaid cuts would impact their communities. When:   12 p.m., Friday, June 27, 2025     Where: Virtual:     Link: https://us02web.zoom.us/j/86765139648?pwd=7IeV1mZ3MO0L9Q7BebMBqzKekznmD8.1     Webinar ID: 867 6513 9648     Passcode: 022980   Why: The cuts to Medicaid and Oklahoma’s directed pa...
-

Bausch + Lomb Announces Closing of Upsized €675 Million Senior Secured Notes Offering and Partial Credit Agreement Refinancing, Including Upsized $2.325 Billion Term Loan Facility

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “company”), a leading global eye health company dedicated to helping people see better to live better, today announced that its subsidiaries, Bausch+Lomb Netherlands B.V. and Bausch & Lomb Incorporated (collectively, the “Issuers”), have closed the upsized offering of €675 million aggregate principal amount of senior secured floating rate notes due 2031 (the “Notes”). In addition, the compa...
-

Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements

BURLINGTON, Mass.--(BUSINESS WIRE)--Bone Biologics Corporation (“Bone Biologics” or the “Company”) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announced that it has received notice from The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that it has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) (the “Rule”) for continued listing on the Nasdaq Capital Market. Bone Biologics is now in compl...
-

Javelin Biotech Strengthens Board with Robin Robinson as Drug Discovery Shifts Towards Human-Based Models

WOBURN, Mass.--(BUSINESS WIRE)--Javelin Biotech appointed Dr. Robin Robinson to its board, reinforcing human-centric drug discovery aligned with the FDA Modernization Act 3.0....
-

Carlsmed Announces Filing of Registration Statement for Proposed Initial Public Offering

CARLSBAD, Calif.--(BUSINESS WIRE)--Carlsmed, Inc. (“Carlsmed”), a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (the “SEC”) relating to a proposed initial public offering of shares of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined....
-

Avvio Medical Proudly Announces ISO 13485 Certification, Marking a Major Milestone in Global MedTech Readiness

SAN FRANCISCO--(BUSINESS WIRE)--Avvio Medical, Inc., a clinical-stage medical device company focused on transforming the treatment of kidney stone disease, is proud to announce that it has successfully achieved ISO 13485:2016 certification following its initial audit conducted by BSI (British Standards Institution). This globally recognized certification demonstrates Avvio’s compliance with international standards for medical device quality management systems and reflects the company’s unwaveri...
-

Envision Healthcare Strengthens Financial Position With Completion of Key Financing Transactions

NASHVILLE, Tenn.--(BUSINESS WIRE)--Envision completes financing transactions, underscoring its commitment to building a sustainable future focused on delivering high-quality care...
-

A.C. Camargo Cancer Center Enhances Security and Patient Care with Help from Advanced Video Surveillance

CHELMSFORD, Mass.--(BUSINESS WIRE)--A.C. Camargo Cancer Center, a leading oncology treatment center in São Paulo, Brazil recognized for its history of innovation, today announced that its partnership with Axis Communications has produced savings of more than $2 million over its first two years, all of which will be reinvested in patient care. A.C. Camargo has deployed more than 2,000 state-of-the-art video surveillance cameras throughout the Center’s corridors, complex care units, and parking l...
-

A.C. Camargo Cancer Center mejora la seguridad y la atención al paciente con la ayuda de la videovigilancia avanzada

CHELMSFORD, Mass.--(BUSINESS WIRE)--A.C. Camargo Cancer Center, un centro líder en tratamiento oncológico en São Paulo, Brasil, reconocido por su historia de innovación, anunció hoy que su asociación con Axis Communications ha producido ahorros de más de $2 millones durante sus primeros dos años, todo lo cual se reinvertirá en la atención al paciente. A.C. Camargo ha desplegado más de 2,000 cámaras de videovigilancia de última generación en todos los corredores del Centro, unidades de atención...
-

A.C. Camargo Cancer Center melhora a segurança e o atendimento ao paciente com a ajuda de videomonitoramento avançado

SÃO PAULO--(BUSINESS WIRE)--O A.C. Camargo Cancer Center, um dos principais centros de tratamento de câncer em São Paulo, Brasil, reconhecido por sua história de inovação, anuncia que sua parceria com a Axis Communications resultou em uma economia de mais de US$ 2 milhões durante os primeiros dois anos, os quais serão reinvestidos no atendimento ao paciente. O A.C. Camargo implantou mais de 2.000 câmeras de videomonitoramento de última geração em todo o Centro, corredores, unidades de atendimen...